The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long term observation

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  1997-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.56.11.661PMID 9462168PMCID PMC1752296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail.

  1996cited by this paper
• Prevention of relapses in systemic lupus erythematosus.

  1995cited by this paper
• Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus.

  1995cited by this paper
• Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies.

  1994cited by this paper
• Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology.

  1993cited by this paper
• The Clinical Significance of Measuring Different Anti-dsDNA Antibodies by Using the Farr Assay, an Enzyme Immunoassay and a Crithidia luciliae Immunofluorescence Test

  1992cited by this paper
• Induction of anti-DNA IgG and IgE antibodies in BALB/c mice.

  1992cited by this paper
• Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.

  1991cited by this paper
• Standards for ANA and anti-DNA

  1990cited by this paper
• Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

  1990cited by this paper
• A comparison of assays used for the detection of antibodies to DNA

  1990cited by this paper
• Antibodies to DNA

  1988cited by this paper
• Measurement of anti-DNA antibodies: a reappraisal using five different methods.

  1987cited by this paper
• Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.

  1986cited by this paper
• Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA).

  1985cited by this paper
• Antibodies to dsDNA and ssDNA in the immunoglobulin classes IgG and IgM: prognostic value in the course of SLE.

  1984cited by this paper
• Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

  1982cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Relationship of renal histopathology in SLE nephritis to immunoglobulin class of anti-DNA.

  1980cited by this paper
• Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus.

  1979cited by this paper
• Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes.

  1979cited by this paper
• DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis.

  1978cited by this paper
• Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus.

  1977cited by this paper
• Disordered immunologic regulation and autoimmunity.

  1976cited by this paper
• Disordered Immunologic Regulation and Autoimmunity

  1976cited by this paper
• The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus.

  1967cited by this paper

• Autoantibody and biomarker detection in the follow-up of autoimmune diseases: state of the art and future perspectives

  2025cites this paper
• An international multicenter retrospective analysis of repeated anti-ENA testing in ANA-associated rheumatic diseases, a data-driven proposal to increase testing efficacy

  2025cites this paper
• Immunoglobulin G/immunoglobulin M autoantibody ratios in incomplete systemic lupus erythematosus

  2024cites this paper
• Autoantibodies to dsDNA in the diagnosis, classification and follow-up of patients with systemic lupus erythematosus

  2023cites this paper
• Targeting plasma cells in systemic autoimmune rheumatic diseases - promises and pitfalls.

  2023cites this paper
• Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.

  2022cites this paper
• Introduction on translational autoimmunity: From bench to bedside

  2022cites this paper
• Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review.

  2022cites this paper
• Laboratory evaluation of anti-dsDNA antibodies.

  2022cites this paper
• IgA anti-dsDNA antibodies: A neglected serological parameter in systemic lupus erythematosus

  2022cites this paper
• EULAR 75-year anniversary: commentaries on ARD papers from 25 years ago

  2022cites this paper
• Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

  2021cites this paper
• Anti-Complement Factor H Autoantibodies May Be Protective in Lupus Nephritis.

  2020cites this paper
• Systemic lupus erythematosus presenting with status epilepticus and acute cardiomyopathy with acute heart failure: case report

  2020cites this paper
• Laboratory Diagnostics

  2019cites this paper
• Association of toll-like receptor 9 expression with prognosis of systemic lupus erythematosus.

  2019cites this paper
• Title Immunogenicity and lupus-like autoantibody production can be linked to each other along with type i interferon production in patients with rheumatoid arthritis treated with infliximab : A retrospective study of a single center cohort

  2019cites this paper
• The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination.

  2018cites this paper
• Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition.

  2018cites this paper
• Kruppel-like factor4 regulates PRDM1 expression through binding to an autoimmune risk allele.

  2017cites this paper
• Urinary mRNA and lupus disease flare

  2017cites this paper
• Insulin resistance in chronic kidney disease

  2017cites this paper
• Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study

  2017cites this paper
• Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review

  2017influential citation
• Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease

  2017cites this paper
• Forspárgildi hækkunar á mótefnum gegn tvístranda DNA fyrir versnunarkast í rauðum úlfum: Safngreining

  2017cites this paper
• Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus

  2016cites this paper
• Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort

  2016cites this paper
• Synthetic oligonucleotide antigens modified with locked nucleic acids detect disease specific antibodies

  2016cites this paper
• Anti-DNA Antibodies

  2016cites this paper
• Assessment of risk factors concerning of systemic lupus erythamatosus on women and outcome of pregnancy at Karbala city

  2015cites this paper
• Mécanismes de la lymphomagenèse au cours des maladies auto-immunes : rôle de la génétique, de l'activité de la maladie et des traitements

  2015cites this paper
• Binding and Dissociation of Biomarkers for Systemic Lupus Erythematosus

  2014cites this paper
• Moving lupus epidemiology forward: returning to the basics

  2014cites this paper
• Evidence Report

  2014cites this paper
• Anti-dsDNA Antibody Isotypes in Systemic Lupus Erythematosus: IgA in Addition to IgG Anti-dsDNA Help to Identify Glomerulonephritis and Active Disease

  2013cites this paper
• Extension of the germinal center stage of B cell development promotes autoantibodies in BXD2 mice.

  2013cites this paper
• Concomitance of IgM and IgG anti-dsDNA Antibodies Does Not Appear to Associate to Active Lupus Nephritis

  2013cites this paper
• Urinary mRNA in systemic lupus erythematosus.

  2013cites this paper
• Chapter 8 – The Structure and Derivation of Antibodies and Autoantibodies

  2013cites this paper
• The prevalence of anti-C1q antibodies in black South Africans with systemic lupus erythematosus and their clinical significance

  2013cites this paper
• Does anti-DNA positivity increase the incidence of secondary antiphospholipid syndrome in lupus patients?

  2013cites this paper
• Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE

  2013cites this paper
• Monitoring of urinary messenger RNA levels for the prediction of flare in systemic lupus erythematosus.

  2012cites this paper
• Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature

  2012cites this paper
• Therapeutic effect of leflunomide on the development of experimental lupus nephritis in mice

  2012cites this paper
• Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India

  2012cites this paper
• B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels

  2012cites this paper
• International consensus for a definition of disease flare in lupus

  2011cites this paper
• Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares

  2011cites this paper
• Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer.

  2011cites this paper
• Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus.

  2010cites this paper
• Myth and reality: practical test system for the measurement of anti‐DNA antibodies in the diagnosis of systemic lupus erythematosus (SLE)

  2010cites this paper
• Quels tests biologiques pour le diagnostic et le pronostic de PR et de connectivite

  2010cites this paper
• Autoantibodies to double-stranded DNA-Intermethod comparison between four commercial immunoassays and a research biosensor-based device

  2010cites this paper
• Systemic lupus Erythematosus: 2 case reports from Eritrea

  2010cites this paper
• Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis

  2009cites this paper
• [Antinuclear antibodies, patterns and characteristics obtained by immunofluorescence. The importance of the IgA, IgM and IgG isotypes].

  2009cites this paper
• Which autoantibodies announce that lupus nephritis is on the way

  2009cites this paper
• Optical biosensor-based characterization of anti-double-stranded DNA monoclonal antibodies as possible new standards for laboratory tests.

  2009cites this paper
• Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study

  2009cites this paper
• Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases

  2009cites this paper
• ANTICUERPOS ANTINUCLEARES, IMAGENES Y CARACTERISTICAS OBTENIDAS POR INMUNOFLUORESCENCIA. IMPORTANCIA DE LOS ISOTIPOS IgA, IgM E IgG

  2009cites this paper
• European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

  2009cites this paper
• Pharmacokinetics of High‐Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation

  2008influential citation
• [The clinical use of auto-antibodies in neurology].

  2008cites this paper
• Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.

  2008cites this paper
• Osteoporosis in SLE

  2008cites this paper
• Induction of Endothelial Cell Apoptosis by IgG Antibodies from SLE Patients with Nephropathy

  2007cites this paper
• Novel biosensor-based analytic device for the detection of anti-double-stranded DNA antibodies.

  2007cites this paper
• Rheumatologie—Teil 2

  2006cites this paper
• Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.

  2006cites this paper
• [Prevalence of antinuclear envelope antibodies and their isotypes in sera positive for antinuclear antibodies].

  2006cites this paper
• Antiendothelial cell antibodies in vasculitis and connective tissue disease

  2006cites this paper
• [Rheumatology-part 2. Research news concerning pathogenesis, epidemiology, diagnosis, and therapy of connective tissue disease].

  2006cites this paper
• Immunity and acquired alterations in cognition and emotion: lessons from SLE.

  2006cites this paper
• Mechanism of action of DNA-hydrolyzing antibodies to DNA from blood of patients with systemic lupus erythematosus

  2006cites this paper
• The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.

  2006cites this paper
• Prevalencia de anticuerpos anti envoltura nuclear y sus isotipos en sueros positivos para anticuerpos antinucleares

  2006cites this paper
• Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus

  2006cites this paper
• Quantitation of Autoantibodies in Systemic Autoimmune Diseases: Clinically Useful?

  2006cites this paper
• The Journal of Rheumatology erythematosus.anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus Prevalence and clinico-serological correlations of anti-alpha-enolase,

  2006cites this paper
• Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.

  2006cites this paper
• The large print giveth and the small print taketh away: preemptive treatment of serologically active, clinically quiet systemic lupus erythematosus.

  2006cites this paper
• Anti‐PCNA autoantibodies preferentially recognize C‐terminal of PCNA in patients with chronic hepatitis B virus infection

  2006cites this paper
• Heteropolymers: a novel technology against blood-borne infections.

  2005cites this paper
• B and C virus infection nuclear antigen in patients with chronic hepatitis Presentation of autoantibody to proliferating cell

  2005cites this paper
• Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.

  2005cites this paper
• Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.

  2005cites this paper
• Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.

  2005cites this paper
• Cross-reactivity of human lupus anti-DNA antibodies with α-actinin and nephritogenic potential

  2005cites this paper
• Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone

  2004cites this paper
• Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.

  2004cites this paper
• Biomarkers in systemic lupus erythematosus

  2004cites this paper
• 10 – ANTI-DNA ANTIBODIES: Structure, Assembly, and Diversity

  2004cites this paper
• pacientes com nefrite lúpica e glomerulopatias

  2004cites this paper
• First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104

  2004cites this paper
• Clinically active serologically quiescent systemic lupus erythematosus.

  2003cites this paper
• Benefit of anti-TNFα treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis

  2003cites this paper
• Successful treatment of resistant giant cell arteritis with etanercept.

  2003cites this paper